Chronic Kidney Disease (CKD) clinical trials in Texas
37 active Chronic Kidney Disease (CKD) trials with a site in Texas. Describe your situation to see which ones look like a fit.
- A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- Ferric Citrate and Chronic Kidney Disease in Children
- A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Pivotal Study of the Velocity™ pAVF System
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
- Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Combination of Novel Therapies for CKD Comorbid Depression
- Diuretic Tuner Clinical Decision Support
- Phosphate Assessment in Chronic Kidney Disease Patients Study
- Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake
- Sickle Cell Kidney Biorepository
- Transformative Research in Diabetic Nephropathy
- Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
- Kidney Health: Eat Well, Live Well
- Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
- Sarcopenia in Chronic Kidney Disease (CKD) Patients
- RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)
- Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression
- Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
- Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial
- Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.